Feedback / Questions
etrasimod (APD334) - Arena
Etrasimod: NDA submission for ulcerative colitis in mid-2022
(Arena)
-
Jun 18, 2020 -
Corporate Presentation
NDA
•
Inflammatory Bowel Disease • Ulcerative Colitis
http://invest.arenapharm.com/static-files/2c12744d-6a44-4459-a750-f161fb87969c
Jun 18, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious